MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Harrison, S; Moussa, S; Bashir, M; Alkhouri, N; Frias, J; Baum, S; Tetri, B; Bansal, M; Taub, R

Published Date

  • April 2018

Published In

Volume / Issue

  • 68 /

Start / End Page

  • S38 - S38

Published By

International Standard Serial Number (ISSN)

  • 0168-8278

Digital Object Identifier (DOI)

  • 10.1016/s0168-8278(18)30292-7